Immune activation in the female genital tract during HIV infection predicts mucosal CD4 depletion and HIV shedding

Journal of Infectious Diseases

Volumn 204, Issue 10, 2011, Pages 1550-1556

  Jaspan, Heather B ^a,e,g   Liebenberg, Lenine ^a   Hanekom, Willem ^a   Burgers, Wendy ^a   Coetzee, David ^b   Williamson, Anna Lise ^a,d   Little, Francesca ^c   Myer, Landon ^b   Coombs, Robert W ^f   Sodora, Don ^g   Passmore, Jo Ann ^a,d  

^a Institute of Infectious Disease and Molecular Medicine   (South Africa)

^b School of Public Health and Family Medicine   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^e SEATTLE CHILDREN S HOSPITAL   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; HLA DR ANTIGEN; KI 67 ANTIGEN; VIRUS RNA;

ADULT; ANTIGEN EXPRESSION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; UTERINE CERVIX; VIRUS LOAD; VIRUS SHEDDING;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CERVIX UTERI; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; VIRAL LOAD; VIRUS SHEDDING;

EID: 80054717746     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir591     Document Type: Conference Paper

References (20)

1. Attia S, Egger M, Muller M, Zwahlen M. Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23:1397-404.
2. Mitchell C, Hitti J, Paul K, et al. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota. AIDS Res Hum Retroviruses 2010; 27:35-39.
3. Gumbi PP, Nkwanyana NN, Bere A, et al. Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T-cell responses in the female genital tract during chronic HIV infection. J Virol 2008; 82:8529-36.
4. Coombs RW, Reichelderfer PS. Landay AL. Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS 2003; 17:455-80. (Pubitemid 36293099)
5. McGowin CL, Popov VL, Pyles RB. Intracellular Mycoplasma genitalium infection of human vaginal and cervical epithelial cells elicits distinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage-mediated killing. BMC Microbiol 2009; 9:139.
6. Fichorova RN, Desai PJ, Gibson FC, Genco CA. Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect Immun 2001; 69:5840-8. (Pubitemid 32786524)
7. Lawn SD, Butera ST. Folks TM. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev 2001; 14:753-77table of contents. (Pubitemid 32979630)
8. Hladick F, Sakchalathorn P, Ballweber L, et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007; 26:257-70. (Pubitemid 46329434)
9. Zhang Z, Schuler T, Zupancic M, et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999; 286:1353-7.
10. Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:859-70. (Pubitemid 29159331)
11. Hazenberg MD, Otto SA, van Benthem BH, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003; 17:1881-8. (Pubitemid 37070273)
12. Milush JM, Reeves JD, Gordon SN, et al. Virally induced CD4+ T cell depletion is not sufficient to induce AIDS in a natural host. J Immunol 2007; 179:3047-56.
13. Columb M, Sagadai S. Multiple comparisons. Curr Anesth Crit Care 2006; 17:233-6. (Pubitemid 44712700)
14. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-71. (Pubitemid 44924494)
15. Hladik F, Lentz G, Delpit E, McElroy A. McElrath MJ. Coexpression of CCR5 and IL-2 in human genital but not blood T cells: implications for the ontogeny of the CCR51 Th1 phenotype. J Immunol 1999; 163: 2306-13. (Pubitemid 29382242)
16. Cohen CR, Moscicki AB, Scott ME, et al. Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa. AIDS 2010; 24:2069-74.
17. van de Wijgert JH, Morrison CS, Cornelisse PG, et al. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr 2008; 48:203-10.
18. Mbulawa ZZ, Coetzee D, Marais DJ, et al. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis 2009; 199:1514-24.
19. Mitchell CM, Balkus J, Agnew KJ, et al. Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines. AIDS Res Hum Retroviruses 2008; 24: 667-71. (Pubitemid 351748782)
20. Rebbapragada A, Howe K, Wachihi C, et al. Bacterial vaginosis in HIVinfected women induces reversible alterations in the cervical immune environment. J Acquir Immune Defic Syndr 2008; 49:520-2.